METHOD FOR DIAGNOSING HEPATIC DEPRESSIVE SYNDROME IN FEMALE PATIENTS DURING THE SECOND PREGNANCY TRIMESTER

medicine. SUBSTANCE: method involves carrying out hemostasis properties examination of pregnant women at the first trimester. Diagnosis value S is calculated as discriminant function on the basis of hemostasis indices of information contents like fibrinogen, activated partial thromboplastin time and prothrombin index during the period of 12 to 28 weeks, from a formula S = 1.380xF1 - 0.019xF2 + 0.074xF3 - 11.156, where F1 is the fibrinogen level in blood serum (in g/l), F2 is the activated partial thromboplastin time (in s), F3 is the prothrombin index activated partial thromboplastin time (in %). S value being less than zero (S0), no hepatic depressive syndrome is to be diagnosed. EFFECT: enhanced accuracy of prediction.